An update today that Integumen (SKIN) “has sought and obtained approval from the Panel on Takeovers and Mergers to extend the deadline for publication of the Offer Document. Integumen currently expects that the Offer Document will be published by Friday 9 October”. But shares in the company currently more than 21% lower at 31.5p – and in prospective acquiree Modern Water (MWG) more than 18% lower at 3.125p?...
“The Boards of Integumen (SKIN) and Modern Water (MWG) are pleased to announce that they have reached agreement on the terms of a recommended offer… for each Modern Water share 1 existing Integumen share… Based on the existing Integumen share closing price of 4.05 pence per existing Integumen share on the last practicable date, the offer values the entire issued and to be issued share capital of Modern Water at approximately £21.25 million”...
Previously writing on Integumen (SKIN), I noted the shares having gone on to more than 2.50p before falling back to a then 1.80p, concluding attempted discounted fundraising ahoy, again? Certainly, at this current juncture for me still avoid / sell. Today “Placing/Subscription to raise £1.368m”…
Previously writing on Integumen (SKIN) last week it was issues a speeding ticket… the shares go still faster! – they then heading towards 2.40p. They went on to more than 2.50p, before this week falling back – and today a further ‘Labskin’ update…
A “Share Price Movement” announcement from ‘Labskin’ technology company Integumen (SKIN) – this including “the transformation of the company has been swift since new management took over in August 2018… part of Integumen's growth strategy involves actively pursuing a broader portfolio of services, that contribute to increased revenues per client, through existing revenue shared collaboration and acquisition options that include, data analytics, software and biophysics integration services. The company is currently involved in a number of such discussions”… and the shares are currently higher today, towards 2.40p…
Shares in skin care and cosmetics company Integumen (SKIN) are currently soaring on the back of a “Trading Update” commencing; “The company is pleased to announce the increased growth in product sales and contract test services at Labskin”…
Writing on Integumen (SKIN) last month, it was argues agreement with “a compelling strategic and financial rationale”, but is the (discounted) placing enough?. Today results for the first half of 2018…
Shares in Integumen (SKIN) are currently 17.5% lower, at 0.70p, on restoration to trading on AIM despite it considering an “investment and licence agreement have a compelling strategic and financial rationale”. Hmmm…
